MAX |
MAX: Protein max |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
1.132 |
Evidence |
|
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
SERPIND1 |
SERPIND1, HCF2: Heparin cofactor 2 precursor |
1.132 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
F11 |
F11: Coagulation factor XI precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
1.132 |
Evidence |
|
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
STAT3 |
|
1.132 |
Evidence |
|
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
1.132 |
Evidence |
|
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
1.132 |
Evidence |
|
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
TESK1 |
TESK1: Dual specificity testis-specific protein kinase 1 |
1.132 |
Evidence |
|
SSH2 |
SSH2, KIAA1725, SSH2L: Protein phosphatase Slingshot homolog 2 |
MAPK15 |
IPI00395861 |
1.132 |
Evidence |
|
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
MAX |
MAX: Protein max |
1.132 |
Evidence |
|
DNAJC13 |
DNAJC13, KIAA0678, RME8: DnaJ homolog subfamily C member 13 |
EPRS |
EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: |
1.132 |
Evidence |
|
MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
SSH1 |
SSH1, KIAA1298, SSH1L: Protein phosphatase Slingshot homolog 1 |
1.132 |
Evidence |
|
CASP1 |
CASP1, IL1BC, IL1BCE: Caspase-1 precursor |
RPS10 |
RPS10: 40S ribosomal protein S10 |
1.132 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
1.132 |
Evidence |
|
F5 |
F5: Coagulation factor V precursor |
EPHA5 |
EPHA5, EHK1, HEK7: Ephrin type-A receptor 5 precursor |
1.132 |
Evidence |
|
CSK |
CSK: Tyrosine-protein kinase CSK |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
1.132 |
Evidence |
|
APOA2 |
APOA2: Apolipoprotein A-II precursor |
PLTP |
PLTP: Phospholipid transfer protein precursor |
1.132 |
Evidence |
|
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
1.132 |
Evidence |
|
FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.132 |
Evidence |
|
SERPINA7 |
SERPINA7, TBG: Thyroxine-binding globulin precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
1.132 |
Evidence |
|
CASP8 |
CASP8, MCH5: Caspase-8 precursor |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
1.132 |
Evidence |
|
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
1.132 |
Evidence |
|
TNFSF14 |
TNFSF14, HVEML, UNQ391/PRO726, LIGHT: Tumor necrosis factor ligand superfamily m |
TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
1.132 |
Evidence |
|